Armata Pharmaceuticals (ARMP) Cash from Operations Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 37.40% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 16.64% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -7.60% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 34.32% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 30.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.96% |
| Dec 31, 2025 | 13.98% |
| Sep 30, 2025 | 25.35% |
| Jun 30, 2025 | 3.99% |
| Mar 31, 2025 | -29.20% |
| Dec 31, 2024 | 2.67% |
| Sep 30, 2024 | -21.32% |
| Jun 30, 2024 | -30.89% |
| Mar 31, 2024 | -24.57% |
| Dec 31, 2023 | -8.75% |
| Sep 30, 2023 | -35.66% |
| Jun 30, 2023 | -46.24% |
| Mar 31, 2023 | -60.72% |
| Dec 31, 2022 | -56.62% |
| Sep 30, 2022 | -31.28% |
| Jun 30, 2022 | -11.82% |
| Mar 31, 2022 | -12.65% |
| Dec 31, 2021 | -39.09% |
| Sep 30, 2021 | -34.95% |
| Jun 30, 2021 | -34.24% |
| Mar 31, 2021 | -15.69% |
| Dec 31, 2020 | -38.56% |
| Sep 30, 2020 | -87.04% |
| Jun 30, 2020 | -9.57% |
| Mar 31, 2020 | -8.66% |
| Dec 31, 2019 | -22.13% |
| Sep 30, 2019 | -13.41% |
| Jun 30, 2019 | -26.30% |
| Mar 31, 2019 | 7.28% |
| Dec 31, 2018 | -11.31% |
| Sep 30, 2018 | 6.82% |
| Jun 30, 2018 | 11.01% |
| Mar 31, 2018 | -15.33% |
| Dec 31, 2017 | 9.54% |
| Sep 30, 2017 | 39.11% |
| Jun 30, 2017 | 1.36% |
| Mar 31, 2017 | 3.67% |
| Dec 31, 2016 | -1.99% |
| Sep 30, 2016 | -7.88% |
| Jun 30, 2016 | -31.67% |